Deletion of integrin α7 subunit does not aggravate the phenotype of laminin α2 chain-deficient mice

被引:0
|
作者
Kinga I. Gawlik
Madeleine Durbeej
机构
[1] Muscle Biology Unit,Department of Experimental Medical Science
[2] Lund University,undefined
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Laminin-211 is a major constituent of the skeletal muscle basement membrane, exerting its biological functions by binding to cell surface receptors integrin α7β1 and dystroglycan (the latter is part of the dystrophin-glycoprotein complex). The importance of these molecules for normal muscle function is underscored by the fact that their respective deficiency leads to different forms of muscular dystrophy with different severity in humans and animal models. We recently demonstrated that laminin α2 chain and members of the dystrophin-glycoprotein complex have overlapping but non-redundant roles despite being part of the same adhesion complex. To analyse whether laminin-211 and integrin α7 subunit have non-redundant functions we generated mice deficient in laminin α2 chain and integrin α7 subunit (dy3K/itga7). We show that lack of both molecules did not exacerbate the severe phenotype of laminin α2-chain deficient animals. They displayed the same weight, survival and dystrophic pattern of muscle biopsy, with similar degree of inflammation and fibrosis. These data suggest that laminin-211 and integrin α7β1 have intersecting roles in skeletal muscle.
引用
收藏
相关论文
共 50 条
  • [1] Deletion of integrin α7 subunit does not aggravate the phenotype of laminin α2 chain-deficient mice
    Gawlik, Kinga I.
    Durbeej, Madeleine
    SCIENTIFIC REPORTS, 2015, 5
  • [2] Thrombospondin-4 deletion does not exacerbate muscular dystrophy in β-sarcoglycan-deficient and laminin α2 chain-deficient mice
    Zaren, Paula
    Gawlik, Kinga I.
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [3] Proteasome inhibition improves the muscle of laminin α2 chain-deficient mice
    Carmignac, Virginie
    Quere, Ronan
    Durbeej, Madeleine
    HUMAN MOLECULAR GENETICS, 2011, 20 (03) : 541 - 552
  • [4] Loss of Dystrophin and β-Sarcoglycan Significantly Exacerbates the Phenotype of Laminin α2 Chain-Deficient Animals
    Gawlik, Kinga I.
    Holmberg, Johan
    Durbeej, Madeleine
    AMERICAN JOURNAL OF PATHOLOGY, 2014, 184 (03): : 740 - 752
  • [5] TRANSGENIC OVEREXPRESSION OF LAMININ α1 CHAIN IN LAMININ α2 CHAIN-DEFICIENT MICE RESCUES THE DISEASE THROUGHOUT THE LIFESPAN
    Gawlik, Kinga I.
    Durbeej, Madeleine
    MUSCLE & NERVE, 2010, 42 (01) : 30 - 37
  • [6] Cardiomyopathy associated with microcirculation dysfunction in laminin α 4 chain-deficient mice
    Wang, JM
    Hoshijima, M
    Lam, J
    Zhou, ZJ
    Jokiel, A
    Dalton, ND
    Hultenby, K
    Ruiz-Lozano, P
    Ross, J
    Tryggvason, K
    Chien, KR
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2006, 281 (01) : 213 - 220
  • [7] Cib2 binds integrin α7Bβ1D and is reduced in laminin α2 chain-deficient muscular dystrophy
    Haeger, Mattias
    Bigotti, Maria Giulia
    Meszaros, Renata
    Carmignac, Virginie
    Holmberg, Johan
    Allamand, Valerie
    Akerlund, Mikael
    Kalamajski, Sebastian
    Brancaccio, Andrea
    Mayer, Ulrike
    Durbeej, Madeleine
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2008, 283 (36) : 24760 - 24769
  • [8] Bortezomib Partially Improves Laminin α2 Chain-Deficient Muscular Dystrophy
    Korner, Zandra
    Fontes-Oliveira, Cibely C.
    Holmberg, Johan
    Carmignac, Virginie
    Durbeej, Madeleine
    AMERICAN JOURNAL OF PATHOLOGY, 2014, 184 (05): : 1518 - 1528
  • [9] Laminin α1 chain mediated reduction of laminin α2 chain deficient muscular dystrophy involves integrin α7β1 and dystroglycan
    Gawlik, KI
    Mayer, U
    Blomberg, K
    Sonnenberg, A
    Ekblom, P
    Durbeej, M
    FEBS LETTERS, 2006, 580 (07): : 1759 - 1765
  • [10] Laminin-α2 Chain-Deficient Congenital Muscular Dystrophy: Pathophysiology and Development of Treatment
    Durbeej, Madeleine
    BASEMENT MEMBRANES, 2015, 76 : 31 - 60